Thursday, October 23, 2014 Last update: 2:33 AM - Covering Large & Obscure Tech Companies Since 1996

Burrill & Company

News articles for Burrill & Company:

Monday, July 1, 2013

Tuesday, June 4, 2013

Wednesday, May 1, 2013

Monday, April 29, 2013

  • Burrill Securities Launches Institutional Breakthrough Series
    NEW YORK, NY -- (Marketwired) -- 04/29/13 -- Gene therapy holds the promise of correcting genetic defects by providing a novel, one-time treatment, or by obviating the need for further chronic protein therapy. Burrill Securities today announced its inaugural Institutional Investor Breakthrough Series: Technology Shaping Tomorrow's Healthcare, which will ... read more

Monday, April 15, 2013

  • Life Sciences Leaders Launch Aging Conference
    SAN FRANCISCO, CA -- (Marketwired) -- 04/15/13 -- Graying populations and the growing burden placed by diseases of aging on healthcare systems around the world are creating a new urgency for the discovery and development of new treatments and cures. The inaugural Burrill & Buck Aging Meeting will bring ... read more

Tuesday, April 2, 2013

Monday, April 1, 2013

  • Two Life Sciences IPOs and Strengthening Markets Offer Encouragement to Sector
    SAN FRANCISCO, CA -- (Marketwire) -- 04/01/13 -- Two companies focused on infectious disease successfully completed IPOs in March, ending a drought in life sciences initial public offerings since the $2.6 billion debut of Pfizer's animal health business Zoetis at the end of January. Watertown, Massachusetts-based Enanta Pharmaceuticals, developing a ... read more

Tuesday, March 19, 2013

Friday, March 1, 2013

  • Sequestration a Blow to Life Sciences
    SAN FRANCISCO, CA -- (Marketwire) -- 03/01/13 -- A total of $85 billion in across-the-board U.S. government spending cuts will be triggered today in the absence of a last-minute Congressional deal to delay or end the threat of sequestration. While the cuts are meant to spread the pain of ... read more

Monday, February 4, 2013

Friday, February 1, 2013

  • Zoetis IPO Caps Strong Month for Life Sciences Financings
    SAN FRANCISCO, CA -- (Marketwire) -- 02/01/13 -- Life sciences financing activity got a strong start in the new year as companies raised $10.3 billion in January. The Pfizer animal health unit Zoetis was responsible for more than half the activity through a debt offering and the largest IPO ... read more

Monday, January 7, 2013

Wednesday, January 2, 2013

Thursday, December 20, 2012

  • Biotech Visionary G. Steven Burrill Offers Predictions on 2013
    SAN FRANCISCO, CA -- (Marketwire) -- 12/20/12 -- As the year comes to a close, biotech visionary G. Steven Burrill issued his annual predictions for the life sciences in the new year. Burrill, CEO of Burrill & Company, a global life sciences financial services firm, says the pace of ... read more

Wednesday, November 14, 2012

  • Burrill & Company Continues Global Expansion With Opening of Moscow Office
    SAN FRANCISCO, CA -- (Marketwire) -- 11/14/12 -- Burrill & Company, a global financial services firm focused exclusively on the life sciences, today announced the opening of its Moscow office to facilitate cross-border financing and dealmaking between life sciences companies. "The Russian Federation represents an emerging economy with strong scientific ... read more

Monday, November 5, 2012

Thursday, November 1, 2012

Sunday, October 7, 2012

  • New Inductees to The Biotech Meeting Hall of Fame Announced
    LAGUNA NIGUEL, CA -- (Marketwire) -- 10/07/12 -- The Biotech Meeting, an annual gathering of life sciences CEOs now in its 25th year, tonight announced the 2012 inductees to The Biotechnology Hall of Fame during its annual awards dinner. The conference is hosted annually for the CEOs by Burrill ... read more

Monday, October 1, 2012

  • Personalized Medicine's Transformation of Healthcare Accelerates
    SAN FRANCISCO, CA -- (Marketwire) -- 10/01/12 -- The life sciences sector continued to outperform the broader markets in September, but developments during the month were notable for highlighting the acceleration of the transformation of healthcare through personalized medicine, Burrill & Company says. "Our healthcare system is dysfunctional and has ... read more

Tuesday, September 4, 2012